James V Alvarez

12PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 03, 2025
Recurrent Breast Cancer Cells Depend on De novo Pyrimidine Biosynthesis to Suppress Ferroptosis.

Kelley R McCutcheon, Josh Wu, Yasemin Ceyhan Ozdemir

|May 05, 2025
APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer.

Nina Marie G Garcia, Jessica N Becerra, Sharan Srinivasan

|Apr 05, 2024
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence.

Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino

|Jul 18, 2023
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer.

Nina Marie G Garcia, Jessica N Becerra, Brock J McKinney

Pageof 2